Ia. Steele et al., Induction of FGF receptor 2-IIIb expression and response to its ligands inepithelial ovarian cancer, ONCOGENE, 20(41), 2001, pp. 5878-5887
Epithelial ovarian cancers (EOCs) arise in the Ovarian Surface Epithelium (
OSE). This tissue is a simple, poorly committed mesothelium which exhibits
characteristics of epithelial and mesenchymal cells when grown in culture.
In contrast, EOCs frequently exhibit properties of complex epithelial tissu
es of the female reproductive tract, such as oviductal, endometrial and cer
vical epithelia, and show induction of expression of epithelial markers suc
h as E-cadherin. Fibroblast Growth Factor Receptor 2 isoform IIIb (FGF rece
ptor 2-IIIb) is a spliced variant of FGF receptor 2 that binds the ligands
FGF-1 and FGF-7 with high affinity, and is expressed exclusively by epithel
ial cells. We have studied the expression of FGF receptor 2-IIIb and its li
gands in primary cultures of normal human OSE, EOC cell lines and snap froz
en tissue from EOCs. Expression of FGF receptor 2-IIIb mRNA is undetectable
in normal OSE, but is expressed in 16/20 (80%) of EOCs. FGFs 1 and 7 mRNAs
are expressed in normal OSE, whilst only 4/20 (20%) and 12/20 (60%) of EOC
s demonstrated expression for these ligands respectively. However, FGF-7 pr
otein was detected in 70% (mean level = 0.7 ng/ml) of ascitic fluids obtain
ed from patients with EOC. FGFs 1 and 7 stimulate DNA synthesis in EOC cell
lines that express FGF receptor 2-IIlb. Moreover, DNA synthesis in these c
ell lines can be partially blocked by blocking antisera to FGFs 1 and 7. It
is suggested that induction of expression of FGF receptor 2-IIIb may play
a role in the development of EOCs by rendering the OSE susceptible to parac
rine and/or autocrine stimulation by its requisite FGF ligands.